<p class="jove_content">The therapeutic application of extracellular vesicles (EVs) has the potential to revolutionize cancer treatment and drug delivery. Chimeric antigen receptor (CAR) cell-derived EVs (CAR-EVs) isolated using ion-exchange chromatography exhibit increased cargo capacity, significantly enhancing their functional efficacy. This study further characterizes CAR-EVs to elucidate their biological activity and therapeutic potential.</p>

enhancing-chimeric-antigen-receptor-extracellular-vesicles-car-ev

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

CAR cell therapies have significantly advanced personalized treatment for several hematological malignancies. Currently, seven CAR-&#8239;cell products ...

Institution - INOVIQ Ltd.

Articles Published in JoVE